David Younger

David Younger

Chief Executive Officer & Co-Founder at A-Alpha Bio
Seattle, Washington, United States

David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company applying synthetic biology and machine learning to engineer and predict protein-protein interactions. He is a co-inventor of the AlphaSeq platform, which enables quantitative measurements used in therapeutic antibody and molecular glue discovery. He previously worked as a postdoctoral researcher at the University of Washington.

Trump-Era Funding Cuts and Hiring Freeze Stall UW Protein Design Startups Led by Nobel Laureate David Baker

The University of Washington's Institute for Protein Design, led by Nobel laureate David Baker, faces a hiring freeze and funding cuts under the Trump administration, stalling its promising protein design startups and reducing opportunities for graduate students and postdocs. Despite Nobel-driven interest and advances in AI-designed proteins, budget constraints threaten future innovation and company spinoffs.

See all 15 stories, episodes and videos about David Younger.

Organizations

See all 4
  • A-Alpha Bio logo
    A-Alpha Bio Executive Officer, Director 2019–present, Chief Executive Officer & Co-Founder 2017–present · current
  • University of Washington logo
    University of Washington Postdoctoral Researcher 2017–2018, Bioengineering Graduate Student 2012–2017 · past
  • Luminex Corporation Engineering Intern 2011 · past

Education

  • University of Washington Doctor of Philosophy (PhD), Bioengineering · 2012–2017
  • Rice University Bachelor of Science; Bachelor of Arts, Bioengineering, Economics · 2007–2012
  • The London School of Economics and Political Science (LSE) Economics · 2009–2010

Online